|Bid||78.66 x 200|
|Ask||78.67 x 200|
|Day's range||78.44 - 78.99|
|52-week range||69.35 - 89.72|
|PE ratio (TTM)||26.50|
|Earnings date||28 Nov 2017|
|Forward Dividend & Yield||1.84 (2.36%)|
|1y target est||89.97|
Partnership Focused on Enabling Care for Chronic, Co-Morbid Patients DUBLIN and BOSTON - October 16, 2017 - Medtronic plc (NYSE:MDT) today announced its Medtronic Care Management Services (MCMS) business ...
Real-World Clinical Data is Key to Creating More Effective Medical Devices and Enabling Better Patient Health DUBLIN and ST. LOUIS - October 13, 2017 - Medtronic plc (NYSE: MDT), the global leader in medical ...
The gloomy eco-political scenario in the United States and Europe points toward the fact that emerging geographies are playing a crucial role in the growth of the MedTech space globally.
Medtronic (MDT:NYSE) By Wells Fargo Securities ($79.81, Oct. 8, 2017) We are downgrading shares of Medtronic from Outperform to Market Perform as we expect a lull in major product cycles and headwinds to result in below average organic sales growth over at least the next few quarters.
With hundreds of workers missing after Hurricane Maria devastated the island, health-care and other firms turned to the airwaves.
Stocks that moved substantially or traded heavily on Monday: General Electric Co., down 96 cents to $23.43 The company said its chief financial officer will leave and named a Trian Fund representative ...
Hurricanes Harvey, Irma and Maria didn't just devastate Texas, Florida and Puerto Rico — medtech players were hit, too.
Wall Street declined on Monday as gains in Microsoft and other technology stocks failed to offset a dip in Medtronic and other healthcare stocks. The S&P healthcare index moved down 0.76 percent, weighed ...
Medtronic (MDT) expects normal manufacturing process in Puerto Rico to resume in full force in the coming weeks with considerable repairing done in the aftermath of Hurricane Maria.
DUBLIN - October 6, 2017 - Medtronic plc (NYSE: MDT) today provided an update on the impact to its manufacturing and sales operations as a result of Hurricane Maria. All four of the company`s business ...
As of October 5, 2017, Intuitive Surgical’s (ISRG) forward PE (price-to-earnings) multiple is 120.3x, which is significantly higher than its peers and the industry average.
A pacemaker for the brain can be used to treat symptoms of neurological disorders like Parkinson’s Disease.
J&J’s Animas will close and exit the insulin pump business, the company said Thursday, citing increased competition that made selling the pumps unsustainable.
Johnson & Johnson's Animas Corp. said Thursday it plans to close operations and exit the insulin pump business. The company will discontinue the manufacturing and sale of its Animas, Vibe and OneTouch ...
Shares of Mazor Robotics (MZOR) surged over 5% on Wednesday to touch a new all-time high. Now the question for investors is: should you consider buying the surgical robotics maker's stock?
The ~$1.1 billion Heartware International deal has strengthened Medtronic’s position in the VAD market, which was estimated to be worth $800 million in 2016.
On September 27, 2017, the FDA approved Medtronic’s HVAD (HeartWare ventricular assist device) system as a destination therapy for advanced heart failure patients.
Medtronic (MDT) aims to leverage its expertise in implantable pump and electronics segments to further improve Heartware’s LVAD (left ventricular assist device) product portfolio.
In 1Q18, Medtronic (MDT) reported a low-single-digit drop in global revenues earned from pacemakers sold to bradycardia patients.